“ Fujifilm is leveraging AI to bring a step-change in clinical accuracy, diagnostic speed, and workflow efficiency across imaging modalities.”
INTERVIEW
Since 2021, we were actively involved in the government’ s aim to eliminate TB and were able to cover the remotest corners of the country. It started with our Never Stop campaign and continued with our CSR initiatives“ Where Innovation Meets Care” joined with“ 100 Days to TB Elimination campaign” and with all our efforts we were able to screen 125,093 individuals for TB using Ultra- Portable Handheld FDR X-Air in 15 states of India where 1,161 people were detected with TB.
We are now gradually transitioning our focus to Women Health and Advocacy wherein through our CSR Campaign“ Find It Early. Fight It Early,” we have aimed to reach more than 200,000 women through Health Risk Assessment where 3000 individuals will be supported with handholding and referral assistance for follow-up diagnostics and care through our medical marketing campaign. The process flow includes – raising awareness and sensitization through Camps in different communities, doing HRA and then referring them for screening.
“ Fujifilm is leveraging AI to bring a step-change in clinical accuracy, diagnostic speed, and workflow efficiency across imaging modalities.”
The program aims to raise awareness about the significance of Breast cancer screening and the associated risk factors. The initiative will educate communities, provide accessible healthcare resources, and empower individuals to take charge of their health. Last year with our Breast Cancer Awareness and Screening campaign we could reach out to 1,01,639 women mostly from the underserved community with 1500 mammography screening making technology more inclusive and pursue women to take a charge of their own health.
What has been the trajectory of the company ' s healthcare revenue growth trajectory over the past 3 – 5 years, particularly in high-impact segments such as CT, MRI, and X-ray?
Over the past 3 – 5 years, FUJIFILM India’ s Medical Systems Division has maintained a robust double-digit growth trajectory, powered by our focus on technology innovation, customer trust, and strategic expansion in high-impact imaging segments such as CT, MRI, and X-ray.
30
BioVoiceNews | September 2025